Open Access
Numéro
Ann Toxicol Anal
Volume 20, Numéro 3, 2008
Page(s) 131 - 136
DOI https://doi.org/10.1051/ata/2009012
Publié en ligne 5 mars 2009
  1. O'Malley P, Johnston LD. Drugs and Driving by American High School Seniors, 2001-2006. J Stud Alcohol Drugs. 2007; 68: 834–842. [PubMed]
  2. Schwilke EW, dos Santos MIS, Logan BK. Changing Patterns of Drug and Alcohol Use in Fatally Injured Drivers in Washington State. J Forensic Sci. 2006; 51(5): 1191–1198. [CrossRef] [PubMed]
  3. Tunbridge R. Conclusions and recommendations of the seminar Pompidou Group. In: Road Traffic and Psychoactive Substances. Strasbourg: Council of Europe Publishing 2004: 377–378.
  4. Krüger HP, Bud Perrine MW, Mettke M, Huessy FB. Illicit drugs in road traffic. Overview of the legal provisions, difficulties faced by police, and analysis of prevention attempts in selected European countries, P-PG/Circrout (98) 4 rev. Council of Europe, Pompidou Group. Strasbourg 1999: 1–29.
  5. Verstraete A. Oral fluid testing for driving under the influence of drugs. History, recent progress and remaining challenges. Forensic Sci Int. 2005; 150(2-3): 143–150. [CrossRef] [PubMed]
  6. Jones AW, Holmgren A, Kugelberg FC. Concentrations of cocaine and its major metabolite benzoylecgonine in blood samples from apprehended drivers in Sweden. Forensic Sci Int. 2008; 177(2-3): 133–139. [CrossRef] [PubMed]
  7. Farrell LJ, Kerrigan S, Logan BK. Recommendations for toxicological investigation of drug impaired driving. J Forensic Sci. 2007; 52(5): 1214–1218. [CrossRef] [PubMed]
  8. Raes E, Verstraete AG. Usefulness of roadside urine drug screening in drivers suspected of driving under the influence of drugs (DUID). J Anal Toxicol. 2005; 29(7): 632–636. [CrossRef] [PubMed]
  9. Höld M, de Boer D, Zuidema J, Maes R. Saliva as an analytical tool in toxicology. Int J Drug Testing. 1996; 1: 1–36.
  10. Mandel ID. The diagnosis use of saliva. J Oral Pathol Med. 1990; 19: 119–125. [CrossRef] [PubMed]
  11. Gorodischer R, Koren G. Salivary excretion of drugs in children: theoretical and practical issues in therapeutic drug monitoring. Dev Pharmacol Ther. 1992; 19: 161–168. [PubMed]
  12. Kaufman E, Lamster I. The diagnostic applications of saliva – a review. Crit Rev Oral Biol Med. 2002; 13: 197–202. [CrossRef] [PubMed]
  13. Haeckel R. Factors influencing the saliva/plasma ratio of drugs. Ann N Y Acad Sci. 1993; 694: 128–142. [CrossRef] [PubMed]
  14. Leute R, Ullman E, Golstein A. Inmunoassay of opiate narcotics in urine and saliva. J Am Med Assoc. 1972; 221: 1231–34. [CrossRef] [PubMed]
  15. Peel H, Perrigo B, Mikhael N. Detection of drugs in saliva of impaired drivers. J Forensic Sci. 1984; 29: 185–189. [PubMed]
  16. Wals J, Flegel R, Crouch D, Cangianelli L, Baudys J. An evaluation of rapid point of collection oral fluid drugs-testing devices. J Anal Toxicol. 2003; 27(7): 429–439. [CrossRef] [PubMed]
  17. Segura J, Ventura R, Jurado C. Derivatization procedures for gas chromatographic-mass spectrometric determination of xenobiotics in biological samples, with special attention to drugs of abuse and doping agents. J Chromatogr B. 1998; 713(1): 61–90. [CrossRef]
  18. Campora P. La espectrometría de masas por impacto electrónico e ionización química en el análisis de drogas de abuso en saliva. Tesis doctoral 2001. Universidad de Santiago de Compostela. Facultad de Medicina. Instituto de Medicina Legal.
  19. Kintz P, Bernhard W, Villain M, Dasser M, Aebi B, Cirimele V. Detection of cannabis use in drivers with the drugwipe device and by GC-MS after intercept device collection. J Anal Toxicol. 2005; 29: 724–727. [CrossRef] [PubMed]
  20. Dickson S, Park A, Nolan S, Kenworthy S, Nicholson C, Midgley J, Pinfold R, Hampton S. The recovery of illicit drugs from oral fluid sampling devices. Forensic Sci Int. 2007; 165: 78–84. [CrossRef] [PubMed]
  21. Speedy T, Baldwin D, Jowet G, Gallina M, Lehanli A. Development and validation of the CozartFormula DDS oral fluid collection device. Forensic Sci Int. 2007; 170(2-3): 117–120. [CrossRef] [PubMed]
  22. Wilson L, Jehanli A, Hand C, Cooper G, Smith R. Evaluation of a rapid oral fluid point-of-care test for MDMA. J Anal Toxicol. 2007; 31(2): 98–104. [CrossRef] [PubMed]
  23. Dams R, Choo R, Lambert W, Jones H, Huestis M. Oral fluid as an alternative matrix to monitor opiate and cocaine use in substances-abuse treatment patients. Drug Alcohol Depend. 2007; 87(2-3): 258–67. [CrossRef] [PubMed]